Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.76777 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.68133 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.71301 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.64936 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.70416 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.78554 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.84975 | 35 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.71048 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67194 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67961 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17475 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.66569 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.71213 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.87177 | 38 |